Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda Banwell

Showing results (131-140 of 251) with videos related to

Pageof 26
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Pilot study of a ketogenic diet in relapsing-remitting MSJ Nicholas Brenton, Brenda Banwell, A G Christina Bergqvist, et al.
Annals of Neurology|February 27, 2024
Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein-Antibody-Associated DiseaseGiulia Fadda, Carmen Yea, Julia O'Mahony, et al.
Transfusion Medicine Reviews|April 3, 2007
Guidelines on the use of intravenous immune globulin for neurologic conditionsTom Feasby, Brenda Banwell, Timothy Benstead, et al.
Pediatrics|October 4, 2006
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reportedGustavo H B Maegawa, Tracy Stockley, Michael Tropak, et al.
Neurology|August 23, 2013
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trialsLeonard H Verhey, Alessio Signori, Douglas L Arnold, et al.
Neurology|May 3, 2019
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSGEmmanuelle Waubant, Brenda Banwell, Evangeline Wassmer, et al.
BMJ Neurology Open|March 21, 2022
Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIG<i>MS</i> StudyLauren Krupp, Brenda Banwell, Tanuja Chitnis, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 11, 2023
Ketogenic diet in relapsing multiple sclerosis: Patient perceptions, post-trial diet adherence & outcomesEmma Wetmore, Diana Lehner-Gulotta, Brian Florenzo, et al.
European Journal of Neurology|March 20, 2024
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysisCaroline Hagbohm, Russell Ouellette, Eoin P Flanagan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 6, 2022
Younger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor EncephalitisAnusha Yeshokumar, Eliza Gordon-Lipkin, Ana Arenivas, et al.
Pageof 26

Showing results (131-140 of 251) with videos related to

Sort By:
Pageof 26
Neurology(R) Neuroimmunology & Neuroinflammation|May 16, 2019
Pilot study of a ketogenic diet in relapsing-remitting MSJ Nicholas Brenton, Brenda Banwell, A G Christina Bergqvist, et al.
Annals of Neurology|February 27, 2024
Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein-Antibody-Associated DiseaseGiulia Fadda, Carmen Yea, Julia O'Mahony, et al.
Transfusion Medicine Reviews|April 3, 2007
Guidelines on the use of intravenous immune globulin for neurologic conditionsTom Feasby, Brenda Banwell, Timothy Benstead, et al.
Pediatrics|October 4, 2006
The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reportedGustavo H B Maegawa, Tracy Stockley, Michael Tropak, et al.
Neurology|August 23, 2013
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trialsLeonard H Verhey, Alessio Signori, Douglas L Arnold, et al.
Neurology|May 3, 2019
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSGEmmanuelle Waubant, Brenda Banwell, Evangeline Wassmer, et al.
BMJ Neurology Open|March 21, 2022
Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIG<i>MS</i> StudyLauren Krupp, Brenda Banwell, Tanuja Chitnis, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 11, 2023
Ketogenic diet in relapsing multiple sclerosis: Patient perceptions, post-trial diet adherence & outcomesEmma Wetmore, Diana Lehner-Gulotta, Brian Florenzo, et al.
European Journal of Neurology|March 20, 2024
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysisCaroline Hagbohm, Russell Ouellette, Eoin P Flanagan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 6, 2022
Younger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor EncephalitisAnusha Yeshokumar, Eliza Gordon-Lipkin, Ana Arenivas, et al.
Pageof 26